Skip to main content
Premium Trial:

Request an Annual Quote

Affy, Chinese University Pen Translational Genomics Alliance; Will Create Lab to Support GeneChip Research

NEW YORK (GenomeWeb News) – Affymetrix and China’s Zhejiang University will jointly develop clinical applications for Affy's GeneChip technology, Affymetrix said today.
 
The partners will also establish a joint laboratory to support researchers from Zhejiang University and six affiliated hospitals that use the GeneChip to analyze genomic information across large patient samples, Affy said.
 
Under the agreement, the university’s Zhejiang California Nanosystem Institute will use the array platform for certain of its research projects, beginning with cancer, newborn genetic diseases, and infectious diseases.
 
According to Affymetrix, the agreement is its first translational medicine collaboration in China.
 
Financial details were not disclosed.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.